Results 171 to 180 of about 3,743 (224)

Redox Imbalance and Mitochondrial Abnormalities in Kidney Disease-Volume II. [PDF]

Biomolecules
Diep TN, Liu H, Wang Y, Wang Y, Hoogewijs D, Yan LJ.   +5 more
europepmc   +1 more source

Pharmacological Potential of Cafestol, a Bioactive Substance in Coffee, in Preventing Ischemia-Reperfusion-Induced Acute Kidney Injury. [PDF]

ACS Omega
Gomes DS, Romanelli MA, Gomes SPS, Brand ALM, da Silva RMV, Oliveira SSC, Santos ALS, Rezende CM, Lara LS.   +8 more
europepmc   +1 more source

Randomized Trial of Dapagliflozin in Patients With Nondiabetic Stage 4 CKD. [PDF]

Kidney Int Rep
Trillini M, Villa A, Perna A, Peracchi T, Fidone D, Rubis N, Guarinoni C, Martinetti D, Chiappa A, Gamba T, Perticucci E, Gambara V, Rota S, Stucchi N, Carrara F, Remuzzi G, Ruggenenti P, ADAPT Study Group.   +17 more
europepmc   +1 more source

Comparative Evaluation of ARB Monotherapy and SGLT2/ACE Inhibitor Combination Therapy in the Renal Function of Diabetes Mellitus Patients: A Retrospective, Longitudinal Cohort Study. [PDF]

Int J Mol Sci
Ngai AW, Baig A, Zia M, Arca-Contreras K, Haque NU, Livetsky V, Rokicki M, Sukhram SD.   +7 more
europepmc   +1 more source

Phosphodiesterase-5 inhibitors: emerging nephroprotective drugs

The Anatolian Journal of Cardiology
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Nephroprotection by antihypertensive therapy

Basic Research in Cardiology, 1998
Morbidity and mortality due to end-stage renal failure has become a major health concern in recent years and there is clear evidence that arterial hypertension constitutes a powerful risk factor for the progression of renal disease. Several studies have documented the benefit of blood pressure control on renal function, and it is increasingly ...
J, Jacobi, R E, Schmieder
openaire   +2 more sources

Potential nephroprotective phytochemicals: Mechanism and future prospects

Journal of Ethnopharmacology, 2022
Kidney disease (KD) is one of the serious health issues, which causes worrisome morbidity and economic burden. Therapeutic strategies are available however majority of them are associated with severe adverse effects and poor patient compliance and adherence. This explorative article was undertaken to provide a holistic review of known nephroprotective (
Parakh Basist, Bushra Parveen, Sultan Zahiruddin, Gaurav Gautam, Rabea Parveen, Mohammad Ahmed Khan, Anuja Krishnan, Mohd Shahid, Sayeed Ahmad   +8 more
openaire   +2 more sources

Nephroprotective Effect of ACE Inhibitors

Drugs, 1993
In most cases of renal disease, progression of renal failure occurs via nonspecific mechanisms that can be dissociated from the primary cause of renal damage. Progression of disease is accompanied by glomerulosclerosis and tubulointerstitial fibrosis.
S, Orth, M, Nowicki, A, Wiecek, E, Ritz
openaire   +2 more sources

Nephroprotective action of sirtuin 1 (SIRT1)

Journal of Physiology and Biochemistry, 2013
Sirtuins, silent information regulator 2 (Sir 2) proteins, belong to the family of NAD(+)-dependent enzymes with deacetylase or mono-ADP-ribosyltransferase activity. These enzymes are responsible for processes of DNA repair or recombination, chromosomal stability and gene transcription.
Dorota, Polak-Jonkisz, Krystyna, Laszki-Szcząchor, Leopold, Rehan, Witold, Pilecki, Henryk, Filipowski, Małgorzata, Sobieszczańska   +5 more
openaire   +2 more sources